Evidence map›Paper›PMID 30249062›Full record

ArticleInternational journal of molecular sciences2018

Inhibitory Effect of Methotrexate on Rheumatoid Arthritis Inflammation and Comprehensive Metabolomics Analysis Using Ultra-Performance Liquid Chromatography-Quadrupole Time of Flight-Mass Spectrometry (UPLC-Q/TOF-MS).

Zhiqiang Pang, Guoqiang Wang, Nan Ran, Hongqiang Lin, Ziyan Wang, Xuewa Guan, Yuze Yuan, Keyong Fang, Jinping Liu, Fang Wang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Anti-Rheumatoid Arthritis Pharmacodynamic Substances Screening ofInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Phenotype-Specific Therapeutic Effect ofInternational journal of molecular sciences · 2019
    Article
  17. Review
  18. Article
  19. Comparative Analysis of Chemical Constituents ofMolecules (Basel, Switzerland) · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Zhiqiang PangDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China. pangzq2812@mails.jlu.edu.cn.
Guoqiang WangDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China. wanggq14@mails.jlu.edu.cn.
Nan RanDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China. rannan17@mails.jlu.edu.cn.
Hongqiang LinResearch Center of Natural Drug, School of Pharmaceutical Sciences, Jilin University, Changchun 130012, China. linhq17@mails.jlu.edu.cn.
Ziyan WangDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China. wzy16@mails.jlu.edu.cn.
Xuewa GuanDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China. guanxw15@mails.jlu.edu.cn.
Yuze YuanDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China. yuanyz17@mails.jlu.edu.cn.
Keyong FangDepartment of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun 130012, China. liujp@jlu.edu.cn.
Jinping LiuResearch Center of Natural Drug, School of Pharmaceutical Sciences, Jilin University, Changchun 130012, China. fangky15@mails.jlu.edu.cn.
Fang WangDepartment of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China. wf@jlu.edu.cn.
Jilin University · CN

Funding

Fundamental Research Funds for the General Universities 451170306058Graduate Innovation Fund of Jilin University 2017139Key Laboratory of Health and Family Planning Commission of Jilin Province of China 3D5172303426Provincial School Co-construction Industrialization Demonstration Project of Jilin Province SXGJSF2017-1-1(01)
6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is a common autoimmune disease. The inflammation in joint tissue and system endanger the human health seriously. Methotrexate have exhibited a satisfactory therapeutic effect in clinical practice. The aim of this research was to establish the pharmacological mechanism of methotrexate on RA therapy. Collagen induced arthritic rats were used to identify how methotrexate alleviates inflammation in vivo. Lipopolysaccharide-induced inflammatory proliferation in macrophages was also be detected in vitro. The activation level of Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and Nucleotide binding domain and leucine-rich repeat pyrin 3 domain (NLRP3)/Caspase-1 and related cytokines were examined by real-time PCR and western blotting or quantified with the enzyme-linked immunosorbent assay. Comprehensive metabolomics analysis was performed to identify the alteration of metabolites. Results showed that treating with methotrexate could alleviate the inflammatory condition, downregulate the activation of NF-κB and NLRP3/Caspase-1 inflammatory pathways and reduce the level of related cytokines. Docking interaction between methotrexate and caspase-1 was visualized as six H-bonds indicating a potential inhibitory effect. Metabolomics analysis reported three perturbed metabolic inflammation related pathways including arachidonic acid, linoleic acid and sphingolipid metabolism. These findings indicated that methotrexate could inhibit the onset of inflammation in joint tissue by suppressing the activation of NF-κB and NLRP3/Caspase-1 pathways and regulating the inflammation related metabolic networks.

Indexed as

MetabolomicsAnimalsAntirheumatic AgentsArthritis, ExperimentalArthritis, RheumatoidBiomarkersChromatography, LiquidCytokinesInflammationMaleMethotrexateRatsRats, WistarSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAntirheumatic AgentsBiomarkersCytokinesMethotrexateinflammationlipid metabolismmetabolomicsmethotrexaterheumatoid arthritis

Identifiers

PMID30249062
PMCPMC6212996
OpenAlexW2889591341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.